Yu Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yu Zhang has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Pinan Liu
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, PR China
3 shared publications - Xin Ma
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China
3 shared publications - Zhijun Yang
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, PR China
2 shared publications Chao Zhang
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
1 shared publication- Hongyu Wu
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China
1 shared publication - Hongyu Wu
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China
1 shared publication
Latest Publications
- Open Access
- 27 May 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (6) , 310
Clinical Features and Key Prognostic Indicators of Growth Hormone-Secreting Pituitary Adenomas: A Retrospective Study of 344 Cases
Background: In growth hormone-secreting pituitary adenomas (GHPA), postoperative hormonal non-remission and tumor recurrence determine clinical prognosis. Notably, some patients exhibit persistent hormonal abnormalities despite intraoperative gross total resection (GTR). This study systematically analyzes the prognostic risk factors in GHPA. Methods: This study collected clinical information from 344 GHPA patients. Univariate and multivariate regression analyses were performed to screen independent risk factors for hormonal non-remission, tumor recurrence, and hormonal non-remission after GTR. Nomograms were established for predicting hormonal non-remission and 3-/5-year recurrence probabilities. Subgroup comparisons were performed to further analyze significant risk factors. Results: Multivariate Logistic regression identified recurrent cases (p = 0.009), preoperative GH > 40 ng/mL (p = 0.043), not GTR (p < 0.001), and Knosp grade IV (p = 0.004) as independent risk factors of postoperative hormonal non-remission. For patients who underwent GTR, the recurrent status (p = 0.016) and Knosp grade III/IV (p = 0.049/0.009) remained significant risk factors for hormonal non-remission. Multivariate Cox regression showed preoperative GH > 40 ng/mL (p = 0.002), hormonal non-remission (p = 0.037), Knosp grade IV (p = 0.025), and vision defect (p = 0.010) as independent risk factors for tumor recurrence. The nomograms had good discrimination and calibration, with test set AUCs of 0.828 for hormonal non-remission, 0.82 for 3-year recurrence, and 0.859 for 5-year recurrence. Subgroup analysis revealed that recurrent cases, compared to initial cases, had younger patient ages, higher Knosp grades, harder tumor textures, and generally higher Ki-67 indices (all p < 0.05). Further analysis demonstrated that, relative to Knosp grade III tumors, grade IV lesions were larger, firmer, and associated with significantly lower rates of both GTR and hormonal remission, alongside a higher recurrence risk (all p < 0.05). Conclusions: Patients with high preoperative GH levels, higher Knosp grades, and recurrence often have a poorer prognosis after treatment. These results support stratified postoperative management and individualized monitoring of GHPA patients.
- 27 May 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (6) , 310
Open AccessClinical Features and Key Prognostic Indicators of Growth Hormone-Secreting Pituitary Adenomas: A Retrospective Study of 344 Cases
Background: In growth hormone-secreting pituitary adenomas (GHPA), postoperative hormonal non-remission and tumor recurrence determine clinical prognosis. Notably, some patients exhibit persistent hormonal abnormalities despite intraoperative gross total resection (GTR). This study systematically analyzes the prognostic risk factors in GHPA. Methods: This study collected clinical information from 344 GHPA patients. Univariate and multivariate regression analyses were performed to screen independent risk factors for hormonal non-remission, tumor recurrence, and hormonal non-remission after GTR. Nomograms were established for predicting hormonal non-remission and 3-/5-year recurrence probabilities. Subgroup comparisons were performed to further analyze significant risk factors. Results: Multivariate Logistic regression identified recurrent cases (p = 0.009), preoperative GH > 40 ng/mL (p = 0.043), not GTR (p < 0.001), and Knosp grade IV (p = 0.004) as independent risk factors of postoperative hormonal non-remission. For patients who underwent GTR, the recurrent status (p = 0.016) and Knosp grade III/IV (p = 0.049/0.009) remained significant risk factors for hormonal non-remission. Multivariate Cox regression showed preoperative GH > 40 ng/mL (p = 0.002), hormonal non-remission (p = 0.037), Knosp grade IV (p = 0.025), and vision defect (p = 0.010) as independent risk factors for tumor recurrence. The nomograms had good discrimination and calibration, with test set AUCs of 0.828 for hormonal non-remission, 0.82 for 3-year recurrence, and 0.859 for 5-year recurrence. Subgroup analysis revealed that recurrent cases, compared to initial cases, had younger patient ages, higher Knosp grades, harder tumor textures, and generally higher Ki-67 indices (all p < 0.05). Further analysis demonstrated that, relative to Knosp grade III tumors, grade IV lesions were larger, firmer, and associated with significantly lower rates of both GTR and hormonal remission, alongside a higher recurrence risk (all p < 0.05). Conclusions: Patients with high preoperative GH levels, higher Knosp grades, and recurrence often have a poorer prognosis after treatment. These results support stratified postoperative management and individualized monitoring of GHPA patients.
- Open Access
- 23 February 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (2) , 484
Identification and Validation of Signature Genes in Invasiveness-Associated Modules of Nonfunctioning Pituitary Adenomas
Background: Invasive non-functional pituitary adenomas (NFPAs) are associated with high recurrence and unfavorable clinical outcomes, yet their underlying molecular mechanisms remain incompletely understood. This study aimed to identify robust biomarkers of invasiveness by integrating transcriptional networks, machine learning, and epigenetic regulation. Methods: RNA sequencing was performed on 32 NFPA samples (15 invasive, 17 non-invasive). Weighted gene co-expression network analysis (WGCNA) was used to identify invasiveness-associated modules, which were validated in public datasets (GSE169498, GSE51618). Candidate genes were prioritized using machine learning, and their epigenetic regulation was studied using DNA methylation datasets (GSE207937, GSE115783). Results: We identified a five-gene signature associated with invasiveness (KIFC3, PNMA3, ARHGAP18, LRRC10B, and KCNC4). All five genes were consistently downregulated in invasive NFPAs (all p < 0.01) and were enriched in oxidative phosphorylation and neuroactive ligand–receptor interaction pathways. A machine learning validation approach (Random Forest followed by forward stepwise logistic regression) showed strong discriminative performance for this signature (mean AUC = 0.919). DNA methylation analyses indicated no robust differences at the genome-wide level or across promoter regions of the core genes; nevertheless, several locus-specific CpG sites (e.g., near KIFC3) showed suggestive methylation changes. Conclusions: Using an integrative multi-omics framework, we identified a novel five-gene signature associated with NFPA invasiveness. The coordinated downregulation of these genes may reflect alterations in cellular energy metabolism and microenvironmental signaling. Although the signature demonstrated promising diagnostic potential, its transcriptional repression is unlikely to be primarily explained by DNA methylation. These findings provide candidate markers and mechanistic hypotheses for understanding invasive NFPA and developing risk-stratification tools.
- 23 February 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (2) , 484
Open AccessIdentification and Validation of Signature Genes in Invasiveness-Associated Modules of Nonfunctioning Pituitary Adenomas
Background: Invasive non-functional pituitary adenomas (NFPAs) are associated with high recurrence and unfavorable clinical outcomes, yet their underlying molecular mechanisms remain incompletely understood. This study aimed to identify robust biomarkers of invasiveness by integrating transcriptional networks, machine learning, and epigenetic regulation. Methods: RNA sequencing was performed on 32 NFPA samples (15 invasive, 17 non-invasive). Weighted gene co-expression network analysis (WGCNA) was used to identify invasiveness-associated modules, which were validated in public datasets (GSE169498, GSE51618). Candidate genes were prioritized using machine learning, and their epigenetic regulation was studied using DNA methylation datasets (GSE207937, GSE115783). Results: We identified a five-gene signature associated with invasiveness (KIFC3, PNMA3, ARHGAP18, LRRC10B, and KCNC4). All five genes were consistently downregulated in invasive NFPAs (all p < 0.01) and were enriched in oxidative phosphorylation and neuroactive ligand–receptor interaction pathways. A machine learning validation approach (Random Forest followed by forward stepwise logistic regression) showed strong discriminative performance for this signature (mean AUC = 0.919). DNA methylation analyses indicated no robust differences at the genome-wide level or across promoter regions of the core genes; nevertheless, several locus-specific CpG sites (e.g., near KIFC3) showed suggestive methylation changes. Conclusions: Using an integrative multi-omics framework, we identified a novel five-gene signature associated with NFPA invasiveness. The coordinated downregulation of these genes may reflect alterations in cellular energy metabolism and microenvironmental signaling. Although the signature demonstrated promising diagnostic potential, its transcriptional repression is unlikely to be primarily explained by DNA methylation. These findings provide candidate markers and mechanistic hypotheses for understanding invasive NFPA and developing risk-stratification tools.
- 4 December 2023
- Published by Elsevier in Neurochirurgie
- Vol. 70 (1) , 101515
Internal carotid artery injury during endoscopic transsphenoidal pituitary surgery: risk factors, management
- 4 December 2023
- Published by Elsevier in Neurochirurgie
- Vol. 70 (1) , 101515
Internal carotid artery injury during endoscopic transsphenoidal pituitary surgery: risk factors, management